{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T04:09:55Z","timestamp":1747886995007,"version":"3.41.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007653","name":"Universit\u00e4tsklinikum Jena","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007653","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>The global incidence of intrahepatic cholangiocarcinoma is increasing. Surgical resection remains the gold standard treatment. However, the long-term prognosis remains dismal. The role of serum ferritin in malignant diseases has not been fully elucidated. This study aimed to evaluate the relationship between preoperative serum ferritin levels and patient outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In our retrospective study, we analyzed data from 95 patients who underwent liver resection for intrahepatic cholangiocarcinoma at Jena University Hospital between 2009 and 2023. Comprehensive clinical and pathological data, along with the correlation between Serum ferritin and clinicopathological parameters, were systematically analyzed and compared. Survival rates were determined using the Kaplan-Meier method.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The optimal preoperative serum ferritin cut-off value for overall survival was 303.1\u00a0\u00b5g\/L, with an area under the curve of 0.697 (95% CI (0.592\u20130.801; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The 1-, 3-, and 5-year survival rates were 74.7%, 50.5%, and 43.2%, respectively. Patients with elevated preoperative SF levels demonstrated significantly worse overall survival compared to the low SF group (50.9% vs. 4.5%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). SF had a significant impact on recurrence rates (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The overall recurrence rate in the high-SF group was 67,3%, compared to 43,5% in the low-SF group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Elevated preoperative serum ferritin levels are associated with significantly worse overall and recurrence-free survival in patients with intrahepatic cholangiocarcinoma. Serum ferritin could serve as a valuable adjunct to the tumor marker CA 19\u2009\u2212\u20099.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00423-025-03737-1","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:44:45Z","timestamp":1747817085000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of serum ferritin on overall survival following resection in patients with intrahepatic cholangiocarcinoma"],"prefix":"10.1007","volume":"410","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8056-0800","authenticated-orcid":false,"given":"Laura","family":"Schwenk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-938X","authenticated-orcid":false,"given":"Felix","family":"Dondorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2597-6464","authenticated-orcid":false,"given":"Oliver","family":"Rohland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5943-4781","authenticated-orcid":false,"given":"Aladdin","family":"Ali-Deeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2417-7196","authenticated-orcid":false,"given":"Utz","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9017-2601","authenticated-orcid":false,"given":"Falk","family":"Rauchfu\u00df","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"3737_CR1","unstructured":"Leitlinienprogramm Onkologie der Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e. V. (AWMF) DKeVDudSDKD (2024) Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik und Therapie des Hepatozellul\u00e4ren Karzinoms und bili\u00e4rer Karzinome, Langversion 5.0, 2024, AWMF-Registernummer: 032-053OL"},{"issue":"11","key":"3737_CR2","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/cncr.32803","volume":"126","author":"AA Florio","year":"2020","unstructured":"Florio AA, Ferlay J, Znaor A, Ruggieri D, Alvarez CS, Laversanne M et al (2020) Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012. Cancer 126(11):2666\u20132678","journal-title":"Cancer"},{"issue":"1","key":"3737_CR3","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1038\/s41598-021-83149-5","volume":"11","author":"TH Yu","year":"2021","unstructured":"Yu TH, Chen X, Zhang XH, Zhang EC, Sun CX (2021) Clinicopathological characteristics and prognostic factors for intrahepatic cholangiocarcinoma: a population-based study. Sci Rep 11(1):3990","journal-title":"Sci Rep"},{"issue":"10","key":"3737_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1097\/TP.0000000000003539","volume":"105","author":"IA Ziogas","year":"2021","unstructured":"Ziogas IA, Giannis D, Economopoulos KP, Hayat MH, Montenovo MI, Matsuoka LK et al (2021) Liver transplantation for intrahepatic cholangiocarcinoma: A Meta-analysis and Meta-regression of survival rates. Transplantation 105(10):2263\u20132271","journal-title":"Transplantation"},{"issue":"1","key":"3737_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-018-0912-x","volume":"18","author":"KM Chan","year":"2018","unstructured":"Chan KM, Tsai CY, Yeh CN, Yeh TS, Lee WC, Jan YY et al (2018) Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence. BMC Gastroenterol 18(1):180","journal-title":"BMC Gastroenterol"},{"issue":"8","key":"3737_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.bbagen.2010.03.011","volume":"1800","author":"W Wang","year":"2010","unstructured":"Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV (2010) Serum ferritin: past, present and future. Biochim Biophys Acta 1800(8):760\u2013769","journal-title":"Biochim Biophys Acta"},{"issue":"5596","key":"3737_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/265755a0","volume":"265","author":"JT Hazard","year":"1977","unstructured":"Hazard JT, Drysdale JW (1977) Ferritinaemia in cancer. Nature 265(5596):755\u2013756","journal-title":"Nature"},{"issue":"3","key":"3737_CR8","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4103\/0973-1482.139156","volume":"10","author":"HB Shi","year":"2014","unstructured":"Shi HB, Li XD, Jiang JT, Zhao WQ, Ji M, Wu CP (2014) Serum ferritin is elevated in advanced non-small cell lung cancer patients and is associated with efficacy of platinum-based chemotherapy. J Cancer Res Ther 10(3):681\u2013685","journal-title":"J Cancer Res Ther"},{"issue":"5","key":"3737_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1007\/s13277-012-0426-z","volume":"33","author":"M Kalousov\u00e1","year":"2012","unstructured":"Kalousov\u00e1 M, Krechler T, J\u00e1chymov\u00e1 M, Kub\u011bna AA, Z\u00e1k A, Zima T (2012) Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study. Tumour Biol 33(5):1695\u20131700","journal-title":"Tumour Biol"},{"issue":"1","key":"3737_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/ijlh.12592","volume":"39","author":"S Koyama","year":"2017","unstructured":"Koyama S, Fujisawa S, Watanabe R, Itabashi M, Ishibashi D, Ishii Y et al (2017) Serum ferritin level is a prognostic marker in patients with peripheral T-cell lymphoma. Int J Lab Hematol 39(1):112\u2013117","journal-title":"Int J Lab Hematol"},{"issue":"8","key":"3737_CR11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.7150\/jca.14797","volume":"7","author":"S Lee","year":"2016","unstructured":"Lee S, Song A, Eo W (2016) Serum ferritin as a prognostic biomarker for survival in relapsed or refractory metastatic colorectal Cancer. J Cancer 7(8):957\u2013964","journal-title":"J Cancer"},{"issue":"3","key":"3737_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.15537\/smj.2017.3.16110","volume":"38","author":"H Tingting","year":"2017","unstructured":"Tingting H, Di S, Xiaoping C, Xiaohong W, Dong H (2017) High preoperative serum ferritin predicted poor prognosis in non-metastatic colorectal cancer. Saudi Med J 38(3):268\u2013275","journal-title":"Saudi Med J"},{"issue":"5","key":"3737_CR13","first-page":"1411","volume":"40","author":"HW Hann","year":"1980","unstructured":"Hann HW, Levy HM, Evans AE (1980) Serum ferritin as a guide to therapy in neuroblastoma. Cancer Res 40(5):1411\u20131413","journal-title":"Cancer Res"},{"issue":"1","key":"3737_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1023\/A:1006078521790","volume":"40","author":"Y Sato","year":"1998","unstructured":"Sato Y, Honda Y, Asoh T, Oizumi K, Ohshima Y, Honda E (1998) Cerebrospinal fluid ferritin in glioblastoma: evidence for tumor synthesis. J Neurooncol 40(1):47\u201350","journal-title":"J Neurooncol"},{"issue":"2","key":"3737_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0090-4295(95)80007-7","volume":"45","author":"AW Partin","year":"1995","unstructured":"Partin AW, Criley SR, Steiner MS, Hsieh K, Simons JW, Lumadue J et al (1995) Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor volume. Urology 45(2):211\u2013217","journal-title":"Urology"},{"issue":"4","key":"3737_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000225740","volume":"40","author":"TA Luger","year":"1983","unstructured":"Luger TA, Linkesch W, Knobler R, Kokoschka EM (1983) Serial determination of serum ferritin levels in patients with malignant melanoma. Oncology 40(4):263\u2013267","journal-title":"Oncology"},{"issue":"2","key":"3737_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12032-009-9203-2","volume":"27","author":"S Kukulj","year":"2010","unstructured":"Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z, Poljak-Blazi M (2010) Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med Oncol 27(2):268\u2013277","journal-title":"Med Oncol"},{"issue":"2","key":"3737_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/1097-0142(19900715)66:2<313::AID-CNCR2820660219>3.0.CO;2-J","volume":"66","author":"HW Hann","year":"1990","unstructured":"Hann HW, Lange B, Stahlhut MW, McGlynn KA (1990) Prognostic importance of serum transferrin and ferritin in childhood Hodgkin\u2019s disease. Cancer 66(2):313\u2013316","journal-title":"Cancer"},{"issue":"4","key":"3737_CR19","first-page":"258","volume":"25","author":"D Nitti","year":"1982","unstructured":"Nitti D, Fabris C, Del Favero G, Farini R, Grassi F, Farini A et al (1982) Serum ferritin in pancreatic disease. Accurate Test Malignancy?? Digestion 25(4):258\u2013262","journal-title":"Accurate Test Malignancy?? Digestion"},{"issue":"Pt 1","key":"3737_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/000456329102800105","volume":"28","author":"D Basso","year":"1991","unstructured":"Basso D, Fabris C, Del Favero G, Meggiato T, Panozzo MP, Vianello D et al (1991) Hepatic changes and serum ferritin in pancreatic cancer and other Gastrointestinal diseases: the role of cholestasis. Ann Clin Biochem 28(Pt 1):34\u201338","journal-title":"Ann Clin Biochem"},{"issue":"12","key":"3737_CR21","doi-asserted-by":"publisher","first-page":"e51379","DOI":"10.1371\/journal.pone.0051379","volume":"7","author":"AA Alkhateeb","year":"2012","unstructured":"Alkhateeb AA, Leitzel K, Ali SM, Campbell-Baird C, Evans M, Fuchs EM et al (2012) Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS ONE 7(12):e51379","journal-title":"PLoS ONE"},{"issue":"11","key":"3737_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/jgh.12618","volume":"29","author":"A Facciorusso","year":"2014","unstructured":"Facciorusso A, Del Prete V, Antonino M, Neve V, Crucinio N, Di Leo A et al (2014) Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation. J Gastroenterol Hepatol 29(11):1905\u20131910","journal-title":"J Gastroenterol Hepatol"},{"issue":"11","key":"3737_CR23","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/1097-0142(19830601)51:11<2112::AID-CNCR2820511126>3.0.CO;2-6","volume":"51","author":"WM Melia","year":"1983","unstructured":"Melia WM, Bullock S, Johnson PJ, Williams R (1983) Serum ferritin in hepatocellular carcinoma. A comparison with alphafetoprotein. Cancer 51(11):2112\u20132115","journal-title":"Cancer"},{"issue":"4","key":"3737_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/gut.19.4.294","volume":"19","author":"MC Kew","year":"1978","unstructured":"Kew MC, Torrance JD, Derman D, Simon M, Macnab GM, Charlton RW et al (1978) Serum and tumour ferritins in primary liver cancer. Gut 19(4):294\u2013299","journal-title":"Gut"},{"key":"3737_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.suronc.2019.05.013","volume":"29","author":"SJ Wu","year":"2019","unstructured":"Wu SJ, Zhang ZZ, Cheng NS, Xiong XZ, Yang L (2019) Preoperative serum ferritin is an independent prognostic factor for liver cancer after hepatectomy. Surg Oncol 29:159\u2013167","journal-title":"Surg Oncol"},{"issue":"4","key":"3737_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.20892\/j.issn.2095-3941.2016.0063","volume":"13","author":"XD Xun","year":"2016","unstructured":"Xun XD, Li Q (2016) Surgical treatment of intrahepatic cholangiocarcinoma: a retrospective study of 104 cases. Cancer Biol Med 13(4):469\u2013473","journal-title":"Cancer Biol Med"},{"key":"3737_CR27","doi-asserted-by":"publisher","first-page":"6616062","DOI":"10.1155\/2021\/6616062","volume":"2021","author":"B Ma","year":"2021","unstructured":"Ma B, Meng H, Shen A, Ma Y, Zhao D, Liu G et al (2021) Prognostic value of inflammatory and tumour markers in Small-Duct subtype intrahepatic cholangiocarcinoma after Curative-Intent resection. Gastroenterol Res Pract 2021:6616062","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"3737_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.surg.2019.06.005","volume":"166","author":"F Bagante","year":"2019","unstructured":"Bagante F, Spolverato G, Merath K, Weiss M, Alexandrescu S, Marques HP et al (2019) Intrahepatic cholangiocarcinoma tumor burden: A classification and regression tree model to define prognostic groups after resection. Surgery 166(6):983\u2013990","journal-title":"Surgery"},{"key":"3737_CR29","doi-asserted-by":"publisher","first-page":"559911","DOI":"10.3389\/fonc.2020.559911","volume":"10","author":"J Kong","year":"2020","unstructured":"Kong J, Cao Y, Chai J, Liu X, Lin C, Wang J et al (2020) Effect of tumor size on Long-Term survival after resection for solitary intrahepatic cholangiocarcinoma. Front Oncol 10:559911","journal-title":"Front Oncol"},{"issue":"3","key":"3737_CR30","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/ajt.12591","volume":"14","author":"G Sapisochin","year":"2014","unstructured":"Sapisochin G, Rodr\u00edguez de Lope C, Gastaca M, Ortiz de Urbina J, Suarez MA, Santoyo J et al (2014) Very early intrahepatic cholangiocarcinoma in cirrhotic patients: should liver transplantation be reconsidered in these patients? Am J Transpl 14(3):660\u2013667","journal-title":"Am J Transpl"},{"issue":"6","key":"3737_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1002\/lt.25737","volume":"26","author":"E De Martin","year":"2020","unstructured":"De Martin E, Rayar M, Golse N, Dupeux M, Gelli M, Gnemmi V et al (2020) Analysis of liver resection versus liver transplantation on outcome of small intrahepatic cholangiocarcinoma and combined Hepatocellular-Cholangiocarcinoma in the setting of cirrhosis. Liver Transpl 26(6):785\u2013798","journal-title":"Liver Transpl"},{"issue":"11","key":"3737_CR32","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1155\/2011\/917097","volume":"25","author":"BG Jiang","year":"2011","unstructured":"Jiang BG, Ge RL, Sun LL, Zong M, Wei GT, Zhang YJ (2011) Clinical parameters predicting survival duration after hepatectomy for intrahepatic cholangiocarcinoma. Can J Gastroenterol 25(11):603\u2013608","journal-title":"Can J Gastroenterol"},{"issue":"1","key":"3737_CR33","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13304-010-0007-x","volume":"62","author":"G Nuzzo","year":"2010","unstructured":"Nuzzo G, Giuliante F, Ardito F, De Rose AM, Vellone M, Clemente G et al (2010) Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg 62(1):11\u201319","journal-title":"Updates Surg"},{"issue":"11","key":"3737_CR34","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1093\/jn\/135.11.2664","volume":"135","author":"S Hercberg","year":"2005","unstructured":"Hercberg S, Estaquio C, Czernichow S, Mennen L, Noisette N, Bertrais S et al (2005) Iron status and risk of cancers in the SU.VI.MAX cohort. J Nutr 135(11):2664\u20132668","journal-title":"J Nutr"},{"issue":"4","key":"3737_CR35","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/bjc.1979.232","volume":"40","author":"JA Tappin","year":"1979","unstructured":"Tappin JA, George WD, Bellingham AJ (1979) Effect of surgery on serum ferritin concentration in patients with breast cancer. Br J Cancer 40(4):658\u2013660","journal-title":"Br J Cancer"},{"issue":"3","key":"3737_CR36","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s10549-012-2405-x","volume":"137","author":"AA Alkhateeb","year":"2013","unstructured":"Alkhateeb AA, Han B, Connor JR (2013) Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages. Breast Cancer Res Treat 137(3):733\u2013744","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3737_CR37","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1073\/pnas.0812010106","volume":"106","author":"LG Coffman","year":"2009","unstructured":"Coffman LG, Parsonage D, D\u2019Agostino R Jr., Torti FM, Torti SV (2009) Regulatory effects of ferritin on angiogenesis. Proc Natl Acad Sci U S A 106(2):570\u2013575","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"3737_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1365-2141.1979.tb01142.x","volume":"42","author":"Y Matzner","year":"1979","unstructured":"Matzner Y, Hershko C, Polliack A, Konijn AM, Izak G (1979) Suppressive effect of ferritin on in vitro lymphocyte function. Br J Haematol 42(3):345\u2013353","journal-title":"Br J Haematol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03737-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T08:44:47Z","timestamp":1747817087000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3737"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03737-1","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"166"}}